KOREAN
ENGLISH
COMPANY
PIPELINE
PRODUCTS
R&D
NEWSROOM
CONTACT
KOREAN
ENGLISH
Company Overview
History
Business network
New drug
Health functional food
Diagnostic device
New natural material
Hepa Vision
Joint Chaeum
Slim Line
Corporate Research Institute
Research performance
News
Notice
Recruit
Directions
COMPANY
GENENCELL, a global bio-healthcure company
COMPANY
COMPANY
PIPELINE
PRODUCTS
R&D
NEWSROOM
CONTACT
HISTORY
Company Overview
History
Business network
HISTORY
GENENCELL is taking a leap forward to become a leading group in the global
health cure industry through research and development using advanced techniques.
2021
05
Carried out the contract for the cultivation of Elaeocarpus with a farm
Promotion of cultivation-related contract with Elaeocarpus sylvestris var. elliptcus (Dampalsu) farms
Registered the patent for the medicine of gastritis and gastric ulcer
Registered a patent for a composition for improving retinal diseases of Centella asiatica
04
Selected as the project for a human application test of joint health by Korea Food Research Institute
03
Registered the U.S. patent for herpes zoster medicine
The IPO organizers selected as Hana Financial Investment (CEO) and Eugene Investment & Securities
02
Attracted the investment for a total of 11.2 billion won from Korea Pharma and Leaders Technology Investment
01
Registered the patent for medicine for COVID-19
2020
12
In India, completed phase Ⅱ clinical trial of ES16001 for COVID-19 treatment
11
Registered the patent for composition for prevention and treatment of retinal diseases
Registered the patent for composition from Hordeum vulgare (Malt) ingredient for the improvement of premenstrual syndrome (PMS)
Attracted the investment for 1.5billion won from FEELUX
10
Completion of economic analysis of Elaeocarpus sylvestris var. elliptcus (Dampalsu) raw material
07
Launched the Boyeojuda Slim Line / Madimada Gwanjeol Chaeum
06
Completed phase Ⅰ clinical trial for herpes zoster medicine
Registered the patent for the additional-developed material for the improvement of premenstrual syndrome (PMS) symptoms
2019
02
Applied for a patent related to premenstrual syndrome/eye health (5 total)
2018
12
Signed an obesity treatment patent technology license agreement
09
Registered a patent for hepatitis C treatment
03
Approved by the Ministry of Food and Drug Safety for a phase 1 clinical trial for shingles treatment
01
Registered a patent for shingles treatment
2017
11
Participated as a cooperative organization in the project planned by the Ministry of Agriculture and Forestry (3 years)
Registered a patent for kidney disease treatment
06
Selected as the organizer in the project planned by the Ministry of Agriculture and Forestry (5 years)/free competition project (3 years)
05
Attracted investment from the Korea Technology Guarantee Fund
04
Selected as a start-up support company by the Small and Medium Business Corporation
03
Selected as a technology commercialization company by the Korea Technology Guarantee Fund and certified as a venture company
01
Accredited as a corporate research institute
2016
12
Acquired a patent for shingles treatment
09
Signed an agreement for joint development of hepatitis C treatment as a task of the Ministry of Trade, Industry and Energy
Applied for a patent for immune cell therapy
08
Established GENENCELL Co., Ltd. (August 26, 2016)
2015 ~ 2012
Ministry of Agriculture and Forestry
Hosted the herpes virus suppression natural product development project (3 billion won)
2011 ~ 2008
Ministry of Agriculture and Forestry
Participated in bio cosmetics development technology project (5 billion won)
2007 ~ 2005
Ministry of Education
Participated in future drug development and drug efficacy evaluation (24 billion won)
Ministry of Knowledge Economy
Participated in the bio-improved new drug development project group (10 billion won)